Companies: 10,795·Total market cap: $144.5T
Global Blood Therapeutics, Inc.

Global Blood Therapeutics, Inc.

GBTNASDAQHealthcare
$68.49
+$0.01(+0.01%)
Market Cap$0
P/E Ratio—
52W High$73.02
52W Low$21.65
SEC Filings

Global Blood Therapeutics, Inc. (GBT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001629137 · GBT · NASDAQ · as of Jun 9, 2026

Filing snapshot

736
Total Filings
SC 13G/A
Latest Form
2023-02-14
Most Recent
2015
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001629137 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2022-02-23
Fiscal Year End
Feb 23, 2022
Accession No.
0000950170-22-001781
Primary Document
gbt-20211231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001629137 · Accession 0000950170-22-001781

Latest Key Filings

10-QQuarterly Report
10-Q
2022-08-08
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2022-10-05Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SC 13G/ABeneficial Ownership Report (Amended)
Beneficial Ownership Report (Amended)
2023-02-14
View
SC 13G/ABeneficial Ownership Report (Amended)
Beneficial Ownership Report (Amended)
2023-02-09
View
15-12G15-12G
15-12G
2022-10-17
View
S-8 POSS-8 POS
S-8 POS
2022-10-05
View
S-8 POSS-8 POS
S-8 POS
2022-10-05
View
S-8 POSS-8 POS
S-8 POS
2022-10-05
View
S-8 POSS-8 POS
S-8 POS
2022-10-05
View
S-8 POSS-8 POS
S-8 POS
2022-10-05
View
S-8 POSS-8 POS
S-8 POS
2022-10-05
View
S-8 POSS-8 POS
S-8 POS
2022-10-05
View
S-8 POSS-8 POS
S-8 POS
2022-10-05
View
S-8 POSS-8 POS
S-8 POS
2022-10-05
View
S-8 POSS-8 POS
S-8 POS
2022-10-05
View
S-8 POSS-8 POS
S-8 POS
2022-10-05
View
POSASRPOSASR
POSASR
2022-10-05
View
Showing 1–15 of 364 filingsForm 4 / 144 hidden· 736 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001629137  |  Exchange: NASDAQ · Healthcare

Global Blood Therapeutics, Inc. (NASDAQ: GBT) has submitted 736 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001629137, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Global Blood Therapeutics, Inc.'s most comprehensive regulatory disclosure. The most recent Global Blood Therapeutics, Inc. 10-K was filed on 2022-02-23 for fiscal year ending 2022. Historical GBT 10-K annual reports are available from 2015 through 2022.

Investors researching Global Blood Therapeutics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
MOR SEC Filings →ISEE SEC Filings →ALPN SEC Filings →MRTX SEC Filings →RYZB SEC Filings →CBAY SEC Filings →SWTX SEC Filings →MORF SEC Filings →
→ GBT Financials→ GBT Earnings→ GBT Insider Trades

Frequently Asked Questions

GBT SEC Filings · 8 questions

Global Blood Therapeutics, Inc. (GBT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 736 filings and access original documents at no cost. Global Blood Therapeutics, Inc.'s CIK is 0001629137.

GBT SEC filingsGlobal Blood Therapeutics, Inc. SEC documentsfind GBT 10-K